MASLD Diagnostic Coalition
Our Mission
Advance access to non-invasive diagnostics for metabolic dysfunction-associated steatotic liver disease (MASLD)
We Seek To:
Disseminate relevant education
Align key
stakeholders
Enable adoption of MASLD carepathways
Increase public & payer awareness
Why Now?
1 in 3 adults in the U.S. has MASLD and 83% of patients were not diagnosed. [1]
A liver biopsy can cost from $1,500 to $300,022 depending on the type of procedure.[2]
Access to non-invasive diagnostics is critical for early identification of patients in their disease progression.
Awareness and understanding of diagnostic options remain limited among patients and providers.
Inconsistent payer policies and reimbursement rates create disparities in access
Early Diagnosis enables therapeutic interventions and lifestyle changes
Our founding Members - Leading Experts in MASLD Diagnostics
Advancing diagnostics and emerging treatments are reinforcing the value of early identification for both providers and patients, as the landscape continues to evolve, the time to act and raise awareness is now!